Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis
1996

trkC mRNA Expression in Neuroblastomas

Sample size: 23 publication Evidence: moderate

Author Information

Author(s): M Ryden, R Sehgall, C Dominici, FH Schilling, CF Ib'an-ez, P Kogner

Primary Institution: Karolinska Institute

Hypothesis

Higher levels of trkC mRNA expression correlate with favourable features in neuroblastomas.

Conclusion

Higher trkC mRNA expression is associated with better prognosis in children with neuroblastoma.

Supporting Evidence

  • TrkC expression was detected in 19 out of 23 neuroblastoma tumors.
  • Higher levels of trkC mRNA were found in tumors from younger patients.
  • Children with high trkC mRNA expression had an 83.3% survival rate compared to 20% for those with low expression.

Takeaway

This study found that kids with certain types of neuroblastoma have more of a special protein called trkC, which seems to help them get better.

Methodology

mRNA expression was analyzed using a sensitive RNAase protection assay.

Limitations

The sample size was limited, which may affect the generalizability of the findings.

Participant Demographics

Children diagnosed with neuroblastoma, including various clinical stages.

Statistical Information

P-Value

0.005

Statistical Significance

p<0.012

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication